Exact Sciences Statistics

Total Valuation

Exact Sciences has a market cap or net worth of MXN 348.92 billion. The enterprise value is 376.80 billion.

Market Cap	348.92B
Enterprise Value	376.80B

Important Dates

The next estimated earnings date is Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	188.64M
Shares Outstanding	n/a
Shares Change (YoY)	+2.42%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	0.91%
Owned by Institutions (%)	94.92%
Float	187.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	119.60
PS Ratio	6.17
PB Ratio	7.60
P/TBV Ratio	n/a
P/FCF Ratio	76.99
P/OCF Ratio	49.18
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 140.93, with an EV/FCF ratio of 83.14.

EV / Earnings	-20.82
EV / Sales	6.72
EV / EBITDA	140.93
EV / EBIT	n/a
EV / FCF	83.14

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 1.01.

Current Ratio	2.72
Quick Ratio	2.30
Debt / Equity	1.01
Debt / EBITDA	17.25
Debt / FCF	10.26
Interest Coverage	-3.82

Financial Efficiency

Return on equity (ROE) is -34.54% and return on invested capital (ROIC) is -1.25%.

Return on Equity (ROE)	-34.54%
Return on Assets (ROA)	-1.09%
Return on Invested Capital (ROIC)	-1.25%
Return on Capital Employed (ROCE)	-2.08%
Revenue Per Employee	8.13M
Profits Per Employee	-2.60M
Employee Count	7,000
Asset Turnover	0.49
Inventory Turnover	6.25

Taxes

Income Tax	-150.26M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.08% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.08%
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.66
Average Volume (20 Days)	442

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.49

Income Statement

In the last 12 months, Exact Sciences had revenue of MXN 56.53 billion and -18.10 billion in losses. Loss per share was -96.55.

Revenue	56.53B
Gross Profit	39.25B
Operating Income	-2.02B
Pretax Income	-18.25B
Net Income	-18.10B
EBITDA	1.98B
EBIT	-2.02B
Loss Per Share	-96.55

Full Income Statement

Balance Sheet

The company has 18.40 billion in cash and 46.50 billion in debt, giving a net cash position of -28.10 billion.

Cash & Cash Equivalents	18.40B
Total Debt	46.50B
Net Cash	-28.10B
Net Cash Per Share	n/a
Equity (Book Value)	45.88B
Book Value Per Share	242.18
Working Capital	18.46B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.09 billion and capital expenditures -2.56 billion, giving a free cash flow of 4.53 billion.

Operating Cash Flow	7.09B
Capital Expenditures	-2.56B
Free Cash Flow	4.53B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.42%, with operating and profit margins of -3.58% and -32.01%.

Gross Margin	69.42%
Operating Margin	-3.58%
Pretax Margin	-32.28%
Profit Margin	-32.01%
EBITDA Margin	3.50%
EBIT Margin	-3.58%
FCF Margin	8.02%

Dividends & Yields

Exact Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.42%
Shareholder Yield	-2.42%
Earnings Yield	-5.19%
FCF Yield	1.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exact Sciences has an Altman Z-Score of 1.33 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.33
Piotroski F-Score	5